SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/09/12 Unitedhealth Group Inc 10-K 12/31/11 99:21M |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.44M 3: EX-21.1 Subsidiaries of the Company HTML 196K 4: EX-23.1 Consent of Independent Registered Public HTML 32K Accounting Firm 5: EX-24.1 Power of Attorney HTML 38K 2: EX-12.1 Computation of Ratio of Earnings to Fixed Charges HTML 43K 6: EX-31.1 Certification Pursuant to Section 302 of the HTML 46K Sarbanes-Oxley Act 2002 7: EX-32.1 Certification Pursuant to Section 906 of the HTML 35K Sarbanes-Oxley Act 2002 67: R1 Document and Entity Information HTML 59K 54: R2 Condensed Consolidated Balance Sheets HTML 157K 65: R3 Consolidated Balance Sheets (Parenthetical) HTML 66K 70: R4 Condensed Consolidated Statements of Operations HTML 122K 89: R5 Condensed Consolidated Statements of Changes in HTML 112K Shareholders' Equity 56: R6 Consolidated Statement of Changes in Shareholders HTML 36K equity (Parentheticals) 64: R7 Condensed Consolidated Statements of Cash Flows HTML 169K 48: R8 Description of Business HTML 34K 38: R9 Basis of Presentation HTML 112K 90: R10 Investments HTML 276K 72: R11 Fair Value HTML 305K 71: R12 Property, Equipment and Capitalized Software HTML 55K 77: R13 Goodwill HTML 123K 78: R14 Medical Costs and Medical Costs Payable HTML 62K 75: R15 Commercial Paper and Long-Term Debt HTML 174K 79: R16 Income Taxes HTML 148K 66: R17 Shareholders' Equity HTML 61K 68: R18 Share-Based Compensation HTML 97K 74: R19 Commitments and Contingencies HTML 66K 99: R20 Segment Financial Information HTML 301K 85: R21 Quarterly Financial Data (Unaudited) HTML 76K 60: R22 Schedule I HTML 175K 73: R23 Basis of Presentation (Policy) HTML 203K 62: R24 Basis of Presentation Basis of Presentation HTML 49K (Tables) 29: R25 Investments (Tables) HTML 273K 86: R26 Fair Value (Tables) HTML 295K 94: R27 Property, Equipment and Capitalized Software HTML 52K (Tables) 43: R28 Goodwill (Tables) HTML 127K 42: R29 Medical Costs and Medical Costs Payable Medical HTML 59K Costs And Medical Costs Payable (Tables) 46: R30 Commercial Paper and Long-Term Debt (Tables) HTML 175K 47: R31 Income Taxes Income Taxes (Tables) HTML 147K 49: R32 Shareholders' Equity (Tables) HTML 39K 21: R33 Share-Based Compensation (Tables) HTML 79K 83: R34 Commitments and Contingencies Commitments and HTML 42K Contingencies (Tables) 58: R35 Segment Financial Information (Tables) HTML 289K 61: R36 Quarterly Financial Data (Unaudited) Quarterly HTML 74K Financial Data (Tables) 33: R37 Basis of Presentation Basis of Presentation HTML 64K (Details) 98: R38 Basis of Presentation Medicare Part D (Details) HTML 35K 14: R39 Basis of Presentation Useful lives for property, HTML 35K equipment and capitalized software (Details) 51: R40 Investments (Narrative) (Details) HTML 43K 88: R41 Investments (Short-Term and Long-Term Investments) HTML 89K (Details) 31: R42 Investments (Fair Value of Mortgage-Backed HTML 51K Securities by Credit Rating Origination) (Details) 41: R43 Investments (Amortized Cost and Fair Value of HTML 77K Available-for-Sale Debt Securities by Contractual Maturity) (Details) 45: R44 Investments (Amortized Cost and Fair Value of HTML 63K Held-To-Maturity Debt Securities by Contractual Maturity) (Details) 55: R45 Investments (Fair Value of Available-For-Sale HTML 64K Investments with Gross Unrealized Losses by Investment Type and Length of Time That Individual Securities Have Been in a Continuous Unrealized Loss Position) (Details) 20: R46 Investments (Net Realized Gains) (Details) HTML 52K 37: R47 Fair Value (Narrative) (Details) HTML 49K 16: R48 Fair Value (Financial Assets and Liabilities, HTML 74K Excluding AARP, Measured at Fair Value on a Recurring Basis) (Details) 87: R49 Fair Value (Assets and Liabilities measured at HTML 86K fair value on a recurring basis) (Details) 30: R50 Fair Value (Summary of Fair Value and Carrying HTML 74K Value for Certain Financial Instruments for Which it is Practicable to Estimate Fair Value) (Details) 84: R51 Fair Value (Reconciliation of Assets Measured at HTML 56K Fair Value on a Recurring Basis Using Level 3 Inputs) (Details) 34: R52 Property, Equipment and Capitalized Software HTML 36K Property, Equipment and Capitalized Software (Narrative) (Details) 52: R53 Property, Equipment and Capitalized Software HTML 60K Property, Equipment and Capitalized Software table (Details) 15: R54 Goodwill and Other Intangible Assets Numbers in HTML 39K narrative (Details) 18: R55 Goodwill (Changes in the Carrying Amount of HTML 67K Goodwill by Reporting Segment) (Details) 44: R56 Goodwill and Other Intangible Assets Gross HTML 44K carrying value, accumulated amortization and net carrying value of ther intangible assets (Details) 24: R57 Goodwill and Other Intangible Assets HTML 41K Weighted-average useful lives assigned to finite-lived intangible assets acquired in business combinations (Details) 91: R58 Goodwill and Other Intangible Assets Amortization HTML 42K Expense relating to Intangible Assets (Details) 57: R59 Medical Costs and Medical Costs Payable Narrative HTML 32K (Details) 76: R60 Medical Costs and Medical Costs Payable Medical HTML 58K Costs And Medical Costs Payable (Details) 36: R61 Commercial Paper and Long-Term Debt (Narrative) HTML 49K (Details) 39: R62 Commercial Paper and Long-Term Debt (Commercial HTML 79K Paper and Long-Term Debt) (Details) 82: R63 Commercial Paper and Long-Term Debt Maturities of HTML 49K commercial paper and long-term debt (Details) 80: R64 Commercial Paper and Long-Term Debt (Summary of HTML 42K Effect of Changes in Fair Value of Fair Value Hedges) (Details) 59: R65 Income Taxes Income Tax Narrative (Details) HTML 46K 81: R66 Income Taxes Components of the provision for HTML 54K income taxes (Details) 35: R67 Income Taxes Reconciliation of the tax provision HTML 76K at the U.S. Federal Statutory Rate to the provision for income taxes (Details) 63: R68 Income Taxes Components of deferred income tax HTML 98K assets and liabilities (Details) 93: R69 Income Taxes Reconciliation of the beginning and HTML 50K ending amount of unrecognized tax benefits (Details) 17: R70 Shareholders' Equity (Details) HTML 81K 28: R71 Share-Based Compensation (Narrative) (Details) HTML 82K 53: R72 Share-Based Compensation (Stock Option and SAR HTML 80K Activity) (Details) 23: R73 Share-Based Compensation (Share-Based Compensation HTML 49K Principal Fair Value Assumptions) (Details) 97: R74 Share-Based Compensation (Restricted Share HTML 59K Activity) (Details) 32: R75 Commitments and Contingencies (Details) HTML 51K 25: R76 Commitments and Contingencies Future lease HTML 52K payments (Details) 27: R77 Segment Financial Information (Narrative) HTML 32K (Details) 19: R78 Segment Financial Information (Details) HTML 143K 22: R79 Quarterly Financial Data (Unaudited) Quarterly HTML 58K Financial Data (Details) 69: R80 Schedule I Schedule I Condensed Balance Sheet HTML 154K (Details) 26: R81 Schedule I Condensed Statements of Operations HTML 79K (Details) 92: R82 Schedule I Schedule I Condensed Statements of Cash HTML 111K Flows (Details) 50: R83 Schedule I Numbers in Narrative (Details) HTML 33K 95: XML IDEA XML File -- Filing Summary XML 156K 40: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 3.65M 8: EX-101.INS XBRL Instance -- unh-20111231 XML 5.58M 10: EX-101.CAL XBRL Calculations -- unh-20111231_cal XML 318K 11: EX-101.DEF XBRL Definitions -- unh-20111231_def XML 1.05M 12: EX-101.LAB XBRL Labels -- unh-20111231_lab XML 2.20M 13: EX-101.PRE XBRL Presentations -- unh-20111231_pre XML 1.40M 9: EX-101.SCH XBRL Schema -- unh-20111231 XSD 241K 96: ZIP XBRL Zipped Folder -- 0000731766-12-000009-xbrl Zip 397K
UNH EX 31.1 2011 10K |
1. | I have reviewed this Annual Report on Form 10-K of UnitedHealth Group Incorporated (the “registrant”); |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
President and Chief Executive Officer | |
1. | I have reviewed this Annual Report on Form 10-K of UnitedHealth Group Incorporated (the “registrant”); |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
/s/ DAVID S. WICHMANN | |
David S. Wichmann Executive Vice President and Chief Financial Officer of UnitedHealth Group and President of UnitedHealth Group Operations |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed as of: | 2/9/12 | 4 | ||
Filed on: | 2/8/12 | SC 13G/A | ||
For Period end: | 12/31/11 | 5 | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/14/12 SEC UPLOAD¶ 10/06/17 1:34K Unitedhealth Group Inc. 4/25/12 SEC UPLOAD¶ 10/06/17 1:60K Unitedhealth Group Inc. |